MTOR and head and neck squamous cell carcinoma: Additionally, PIK3CA and/or EGFR amplification and Rictor overexpression in head and neck squamous cell carcinoma and lung squamous cell carcinoma, and the RICTOR amplification detected in our study are associated with the fact that mTOR inhibitors are under investigation in these tumours45,68.